Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

November 27, 2018 By Lynn Fugaro Leave a Comment

PPIs Side Effects

Proton pump inhibitors (PPIs) are used to treat heartburn, ulcers, and symptoms of acid reflux. Recent studies have found an increased risk of developing stomach cancer if you take these drugs. PPIs include popular prescription and over-the-counter (OTC) drugs such as Nexium (esomeprazole) and Prilosec (omeprazole). It was also found that people who used histamin-2 (H2) receptor antagonists, such as Tagamet (cimetidine) and Zantac (ranitidine), did not face the same risk. Further, the risk of developing stomach cancer with PPI use may have been known, or should have been anticipated, as far back as the 1980’s.

Heartburn Medications

PPIs are heavily prescribed, some say very overprescribed, for the following purposes:

  • Treat or prevent ulcers
  • Treat H. pylori infection, in combination with antibiotics
  • Treat symptoms of gastroesophageal reflux disease (GERD), also known as acid reflux
  • Heal erosion of the esophagus caused by acid reflux
  • Treat Barrett’s esophagus
  • Reduce acid production in Zollinger-Ellison syndrome
  • Other conditions in which reduction of stomach acid is beneficial

But PPIs are not your only options. H2 inhibitors are another type of antacid, and they have not been linked to increased instances of stomach cancer.

Increased Risk of Stomach Cancer

Near the end of 2017 two studies were published showing an increased risk of stomach cancer in PPI users. The study published in the journal Gut found that users were more than twice as likely to develop stomach cancer and that the risk increased with long-term use. Another study published in BMJ Open found a threefold increase of stomach cancer cases people using PPIs and none in those using H2 blockers.

If you have developed stomach cancer after or while using PPI drugs, please talk to an experienced defective drug attorney right away to learn more about your rights.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

Filed Under: Cancer, Drug Recalls, Proton pump inhibitors

Avatar

About Lynn Fugaro

Lynn has been writing web content since 2007 after a lengthy career as a middle school English teacher and administrator. Writing web content seemed a natural progression following a career teaching adolescents about the beauty and the power of the written word, and she quickly got hooked on the challenge of writing SEO- and reader-friendly content that could be found on Page 1 of Google and other search engines.

Having written content for physicians and attorneys for the first few years of her writing career, Lynn has most recently produced original, informative, entertaining, and relevant content for the entertainment industry, the automotive industry, senior communities, pet rescues and numerous other businesses hoping to increase website traffic and page views for all clients looking for informative, vibrant content.

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

RSS FDA Med Watch

  • UPDATE: Increased Rate of Mortality in Patients Receiving Abiomed Impella RP System - Letter to Health Care Providers
  • B. Braun Medical Inc. Issues Voluntary Nationwide Recall of Twenty-Two (22) Lots of Blood Administration Sets, Due to Potential for Leakage at the Joint Between the Blood Filters and Tubing
  • Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP, 150mg and 300mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL, Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
  • Precision Dose Inc. Issues Voluntary Nationwide Recall of Ranitidine Oral Solution, USP 150 mg/10 mL Due to Possible Presence of N-nitrosodimethylamine (NDMA) Impurity
  • Update On Device Failure Associated with Getinge's Maquet/Datascope Intra-Aortic Balloon Pumps – Letter to Health Care Providers
  • Device Failure Associated with Getinge's Maquet/Datascope Intra-Aortic Balloon Pumps - Letter to Health Care Providers
  • Medtronic Recalls Remote Controllers for MiniMed Insulin Pumps for Potential Cybersecurity Risks

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Canada Makes Clinical Trial Data Public, Will the FDA Follow Suit?
  • Cosmetic Talcum Powder, Including Baby Powder, a Mesothelioma Risk for Women
  • Bausch Removed Talc Powder from the Shelves Long Before Johnson & Johnson’s Recall

RSS Lawsuits and Settlements

  • Possible Lawsuit: Zantac Medication Cancer Legal News & Lawsuit Information
  • Possible Lawsuit: Gilead HIV Drug Truvada Lawsuit News and Legal Information
  • Possible Lawsuit: Uloric Black Box Warning Legal News and Lawsuit Information

RSS Mass Tort News

  • Xarelto Settlement Faces Legal Challenge
  • Will $33.7 Million IVC Filter Verdict Expedite Mass Settlement?
  • Understanding the Expanding Talcum Powder and Asbestos Litigation

RSS Health Industry

  • Fla. Asks High Court To Find Medical Pot Regs Constitutional
  • Data Breach Victims To Get Up To $6M In Banner Health Deal
  • DC Circ. Doubtful Of Jurisdiction In CareFirst Data Breach Suit

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2019 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in